午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

Business Bank account
Business Address
Basic Contact Infomation
Trade Company

Main products: Compound Libraries,Noval Small Molecucles,Nature Compounds,Inhibitory Antibodies,Life science Kits

Current Location: HOME >> Product
Product Categories
TargetMol Chemicals Inc.
Country: United States
Tel: +1-781-999-5354
Mobile: +17819995354
E-mail: marketing@targetmol.com
QQ:
Skype: Chat Now!
Address: 36?Washington?Street, Wellesley?Hills
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Product Name MF CAS Details
Sericoside C36H58O11 55306-04-2 Details
MK-0249 FA Details
NSC45586 C20H19N6NaO3 6300-44-3 Details
Aureusidin C15H10O6 38216-54-5 Details
ENT-C225 C26H40N4O5 2919962-53-9 Details
O-Succinylhomoserine C8H13NO6 1492-23-5 Details
3-Hydroxypropionic Acid sodium salt C3H5NaO3 6487-38-3 Details
IHMT-PI3Kδ-372 C26H23F2N7O2 2429889-62-1 Details
D-NMAPPD C23H38N2O5 35922-06-6 Details
Cyclo(L-Pro-L-Val) C10H16N2O2 2854-40-2 Details
Stephacidin B C52H54N6O8 360765-75-9 Details
N-acetyl Dapsone C14H14N2O3S 565-20-8 Details
Sulpho NONOate H10N4O5S 61142-90-3 Details
MeTC7 C32H48BrN3O4 1817841-22-7 Details
BRD0418 C29H32N2O5 1565827-99-7 Details
Ametoctradin C15H25N5 865318-97-4 Details
Ardisiacrispin A C52H84O22 23643-61-0 Details
17β-Estradiol sulfate sodium C18H23NaO5S 4999-79-5 Details
S2H97 Details
BMP-4 Protein, Human, Recombinant (E399D) Details
[Tyr3]Octreotate C49H64N10O12S2 302794-43-0 Details
CX717 867276-98-0 Details
MAGL-IN-5 C18H17N3O5 359714-55-9 Details
EBOV-IN-1 C34H43N3O5 1335113-30-8 Details
Muramic acid HCl C9H17NO7.ClH 55226-93-2 Details
JAK1/2/3 Inhibitor 1 C6H2Cl2N2S 16234-14-3 Details
Lats-IN-1 C18H14N4OS 1424635-83-5 Details
OX40/TNFRSF4 Protein, Human, Recombinant (His) Details
MRS 2905 Details
AHR Inhibitor I-103 C21H17FN6 2247951-12-6 Details
(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide C26H23F3N6O 1934246-20-4 Details
Atacicept 845264-92-8 Details
HCV-IN-31 C12H17FN6O3 1998705-62-6 Details
Demcizumab 1243262-17-0 Details
2′,2′-Difluorodeoxyuridine C9H10F2N2O5 114248-23-6 Details
MERS-CoV Spike/S1 Protein (aa 1-725, His) Details
MCTR2 C27H40N2O6S 1784701-62-7 Details
Fibrinogen C6H14O6 9001-32-5 Details
2,4-Diacetylphloroglucinol C10H10O5 2161-86-6 Details
(±)9-HEPE C20H30O3 286390-03-2 Details
WAY-620521 C18H15NO4S 315693-33-5 Details
Tepotinib hydrochloride(1 : x) C29H29ClN6O2 1103508-80-0 Details
SORT-PGRN interaction inhibitor 1 C15H18N2O2 100957-85-5 Details
(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid C18H19NO2 89667-39-0 Details
Ianalumab 1929549-92-7 Details
CLEFMA C23H17Cl2NO4 1246964-32-8 Details
17-oxo-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid C22H32O3 1233715-33-7 Details
Carboxyebselen C14H9NO3Se 153871-75-1 Details
BGT226 C28H25F3N6O2 915020-55-2 Details
Celosin H C47H72O20 1623405-28-6 Details
TLR7 agonist 3 C18H24N4O 1229024-78-5 Details
2-(1-methyl-1H-imidazol-4-yl)acetic acid C6H8N2O2 2625-49-2 Details
Globotetraosylceramides (porcine RBC) C56H102N2O23 11034-93-8 Details
NBC 19 C24H26BCl3N2O2 2068818-75-5 Details
Bemnifosbuvir C24H33FN7O7P 1998705-64-8 Details
TAPI1 C26H37N5O5 163847-77-6 Details
Dazonone C11H10ClN3O 105622-85-3 Details
CP 465022 C26H24ClFN4O 199655-36-2 Details
G3-C12 acetate(848301-94-0 free base) Details
BW A868C C25H37N3O5 118675-50-6 Details
Speract TFA(76901-59-2(free base)) Details
Etidocaine C17H28N2O 36637-18-0 Details
6α-Hydroxy-5α-cholestane C27H48O2 41083-73-2 Details
CP-91149 C21H21ClN3O3 186392-40-5 Details
(R)-Mephenytoin C12H14N2O2 71140-51-7 Details
5-Ethynyluridine C11H12N2O6 69075-42-9 Details
BMY-14802 C18H22F2N4O 105565-56-8 Details
IACS-13909 C17H18Cl2N6 2160546-07-4 Details
JI6 C19H17N3O4S 856436-16-3 Details
FiVe1 C18H16Cl2N4 932359-76-7 Details
KYP-2047 C20H25N3O2 796874-99-2 Details
SIGIRR Protein, Human, Recombinant (His) Details
GDF-15 Protein, Mouse, Recombinant (hFc) Details
Compound CDy9 C15H16N2O5S 952306-80-8 Details
MY10 C15H10F6OS2 2204270-73-3 Details
CXCL-CXCR1/2-IN-1 C14H8Cl2N4O3S 2415653-55-1 Details
LEM-14 C25H26N4O4S 1814881-70-3 Details
WEE1-IN-3 C28H31N7O2 2272976-28-8 Details
JMJD6 inhibitor WL12 C16H11N3O2 899548-78-8 Details
4'-Methoxyflavanone C16H14O3 97005-76-0 Details
H-D-Phe-Pip-Arg-pNA dihydrochloride C27H37ClN8O5 62354-65-8 Details
Soticlestat C23H23N3O2 1429505-03-2 Details
NAE-IN-M22 C20H24Cl2N2 864420-54-2 Details
20-HEPE C20H30O3 116477-57-7 Details
VEGFR2-IN-2 C15H11BrN2O 737818-56-3 Details
MC2590 C20H17N3O3 2284460-01-9 Details
CAY10464 C15H12Cl2O 688348-37-0 Details
12-oxo Leukotriene B4 C20H30O4 136696-10-1 Details
N-phenylthiophene-2-carboximidamide C11H10N2S 3737-39-1 Details
ALR2-IN-1 C16H17N3O2S 2799695-54-6 Details
Resolvin E2 C20H30O4 865532-70-3 Details
Cerlapirdine C22H23N3O3S 925448-93-7 Details
5-Octyl-α-ketoglutarate C13H22O5 1616344-00-3 Details
AVN 322 free base C17H19N5O2S 1194574-33-8 Details
Ciprostene (calcium salt) C22H38CaO4 81703-55-1 Details
Avotaciclib C13H11N7O 1983983-41-0 Details
MAT2A-IN-9 C14H8ClF3N4O 2439277-80-0 Details
N4-Acetylsulfamethoxazole C12H13N3O4S 21312-10-7 Details
(4R)-RO5263397 C10H11FN2O 1357266-80-8 Details
2-Hydroxymethyl-5-hydroxypyridine C6H7NO2 40222-77-3 Details
Product Total: Product Page:
248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324